APA (7th ed.) Citation

Goldblatt, D., Southern, J., Andrews, N. J., Burbidge, P., Partington, J., Roalfe, L., . . . Miller, E. (2018). Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants: A multicentre, parallel group randomised controlled trial. Lancet Infectious Diseases, 18(2), 171. https://doi.org/10.1016/S1473-3099(17)30654-0

Chicago Style (17th ed.) Citation

Goldblatt, David, et al. "Pneumococcal Conjugate Vaccine 13 Delivered as One Primary and One Booster Dose (1 + 1) Compared with Two Primary Doses and a Booster (2 + 1) in UK Infants: A Multicentre, Parallel Group Randomised Controlled Trial." Lancet Infectious Diseases 18, no. 2 (2018): 171. https://doi.org/10.1016/S1473-3099(17)30654-0.

MLA (9th ed.) Citation

Goldblatt, David, et al. "Pneumococcal Conjugate Vaccine 13 Delivered as One Primary and One Booster Dose (1 + 1) Compared with Two Primary Doses and a Booster (2 + 1) in UK Infants: A Multicentre, Parallel Group Randomised Controlled Trial." Lancet Infectious Diseases, vol. 18, no. 2, 2018, p. 171, https://doi.org/10.1016/S1473-3099(17)30654-0.